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Abstract
The ability of an enzyme to select and act upon a specific class of compounds with unerring precision and efficiency is an
essential feature of life. Simultaneously, these enzymes often catalyze the reaction of a range of similar substrates of the
same class, and also have promiscuous activities on unrelated substrates. Previously, we have established a methodology to
quantify promiscuous activities in a wide range of proteins. In the current work, we quantitatively characterize the active site
for the ability to catalyze distinct, yet related, substrates (BRASS). A protein with known structure and active site residues
provides the framework for computing ‘duplicate’ residues, each of which results in slightly modified replicas of the active
site scaffold. Such spatial congruence is supplemented by Finite difference Poisson Boltzmann analysis which filters out
electrostatically unfavorable configurations. The congruent configurations are used to compute an index (BrassIndex),
which reflects the broad substrate profile of the active site. We identify an acetylhydrolase and a methyltransferase as
having the lowest and highest BrassIndex, respectively, from a set of non-homologous proteins extracted from the Catalytic
Site Atlas. The acetylhydrolase, a regulatory enzyme, is known to be highly specific for platelet-activating factor. In the
methyltransferase (PDB: 1QAM), various combinations of glycine (Gly38/40/42), asparagine (Asn101/11) and glutamic acid
(Glu59/36) residues having similar spatial and electrostatic profiles with the specified scaffold (Gly38, Asn101 and Glu59)
exemplifies the broad substrate profile such an active site may provide. ‘Duplicate’ residues identified by relaxing the spatial
and/or electrostatic constraints can be the target of directed evolution methodologies, like saturation mutagenesis, for
modulating the substrate specificity of proteins.
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Introduction
The remarkable ability of enzymes to selectively catalyze the
reactions of compounds from the cellular soup is essential for the
proper functioning of most pathways in biological systems [1,2].
Simultaneously, evolution has endowed these enzymes with
flexibility and plasticity to catalyze the conversion of a wide range
of related substrates [3–5]. In certain cases, such broad substrate
specificity poses serious concerns, as in the emergence of extended-
spectrum b-lactamases generating multiresistant strains of bacteria
[6,7]. The structural and molecular basis of broad substrate
specificity has been the subject of intense research in diverse fields
like drug design, industrial applications, etc. [8–12]. Substrate
transition state stabilization is another trait that has been selected
for during evolution, since it ensures high catalytic efficiency [13].
A quantitative measure of broad substrate specificity is yet to be
formalized. A previous attempt to quantify broad substrate
specificity provided a measure of the catalytic efficiencies of an
enzyme toward a pre-defined set of substrates, but was limited in
its scope and scalability [14]. A trait related to broad substrate
specificity is promiscuity, which is defined as the catalysis of
reactions distinct from the one the protein has evolved to perform,
but using the same active site scaffold [15–18]. Previous work by
our group has established a methodology to quantify promiscuous
activities in a wide range of proteins [19,20].
In the current work, we quantitatively characterize the active
site of an enzyme to measure broad substrate specificity - Broad
substrate specificity estimator (BRASS). BRASS computes ‘du-
plicate’ residues from the structure of a protein with known active
site residues. These ‘duplicate’ residues generate slightly modified
replicas of the active site scaffold. Finite difference Poisson
Boltzmann analysis is used to filter out electrostatically unfavorable
configurations [21,22]. We compute an index (BrassIndex) by the
number of configurations that are equivalent to the active site
scaffold, such that at least one residue in each new configuration is
present in the original active site motif. Thus, we ignore any
possible moonlighting functions, where the main active site would
not be the host to the catalytic residues [23].
We identified an acetylhydrolase and a methyltransferase as
having the lowest and highest BrassIndex, respectively, from a set
of proteins extracted from the Catalytic Site Atlas [24]. Moreover,
there was no correlation found between the BrassIndex and the
promiscuity index (as computed in [20]) of a protein. BRASS
analysis can be easily adapted to directed evolution methodologies.
The target residues can be identified by relaxing the spatial and/or
electrostatic constraints in the current flow, and these ‘duplicate’
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residues can be subjected to saturation mutagenesis which selects
for high specificity with respect to a desired substrate [13]. To
summarize, we present a methodology for detecting congruent
scaffolds in the active site of a protein, which we hypothesize
results in broad substrate specificity. We quantitatively character-
ize these properties in a wide range of proteins.
Results
Table 1 shows the proteins with the highest and lowest degree of
substrate specificity as defined by the index (BrassIndex) computed
by BRASS. BRASS identified an acetylhydrolase as a protein with
the lowest BrassIndex, and a methyltransferase and a thioesterase
as proteins possessing the highest BrassIndex in the set of 420
proteins under consideration. We now discuss each of these three
proteins with respect to their active sites.
1. Highest BrassIndex: rRNA Methyltransferase
(PDBid:1QAM)
The critical role of the ribosome as the site for protein synthesis
in cell viability makes it the logical target for a wide range of drugs
[25]. In response to the drug challenge, pathogens develop
resistance through mutations and methylations [26]. Methyltrans-
ferases (MTases) transfer a methyl group from a donor to an
acceptor, and catalyze a diverse range of substrates (small organic
molecules, DNA, RNA, proteins, lipids) [27]. The rRNA MTase
ErmC’ methylates an adenine base in 23S rRNA, which confers
resistance by obstructing the contact site for the antibiotics [28].
Fig. 1a shows the site in the rRNA MTase ErmC’ (PDBid:1-
QAM) that binds the cofactor S-adenosyl-L-methionine (AdoMet).
It can be seen that the residues Gly/38/40/42, Asn101/11 and
Glu59/36 present possible combinations that are spatially and
electrostatically congruent (Table 2). It has been noted that``in the
AdoMet complex, the positively charged sulfur atom of the
methionine moiety interacts with main-chain carbonyl groups of
Asn11 and Asn101" [28]. Furthermore, in the proposed transition
state of transmethylation catalyzed by ErmC’, a ‘‘favorable region
for accommodating the N6 of adenine’’ has been observed due to
contact with the O atom of Asn101 and Asn11 [28]. Thus, the
active site can be seen to both stabilize the cofactor, as well as
provide a binding site for a broad profile of recognized substrates.
The broad substrate profile of the enzyme is amply demonstrated
by its ability to methylate increasingly truncated nucleotide
transcripts of the domain methylated in 23S rRNA, down to a
minimal of a 27 nucleotide long stem-loop sequence [29].
2. High BrassIndex: Palmitoyl-protein Thioesterase
(PDBid:1EH5)
Palmitoylation is a critical protein modification that governs
protein-protein interactions, protein trafficking and membrane
localization [30,31]. Depalmitoylation is known to be carried out
either by lysosomic or cytoplasmic thioesterases [32]. Palmitoyl-
protein thioesterase 1 (PPT1) is a lysosomal enzyme that is
responsible for the removal of fatty acyl groups from cysteine
residues in modified proteins [33]. Mutations in the gene that
encodes PPT1 have been ascertained as the primary cause of
neuronal ceroid lipofuscinoses, a family of recessively inherited
childhood neurodegenerative disorders. In the PPT1 protein
(PDBid: 1EH5), multiple glutamines (Gln116/119/182) are
spatially and electrostatically equivalent to the catalytic triad
(His289, Asp233 and Ser115) (Fig. 1b and Table 3). Interestingly,
the Asp233 has an equivalent Asp288 in its close vicinity, which
might constitute another triad for proteolytic purposes. This
hypothesis is apparently refuted by the fact that the D233N
mutant resulted in null activity. However, this loss in activity might
be due to an improperly folded protein - as is believed to have
happened for the triple mutant Asn(197/212/232)Gln by Bellizzi
et al. [33]. The Asp288 triad theory garners more support from
the fact that the identity of the third member of the catalytic triad
could not be ascertained before the completion of the structure
determination, as several candidates were suggested by the
mutagenesis data, and that ‘‘Asp233 was a surprising finding’’
[33].
Moreover, PPT1 is known to have a much broader substrate
profile than a related thioesterase (PPT2), with which it shares
26% identity [32,34]. This corroborates the high BrassIndex
computed for PPT2 using BRASS. Firstly, BRASS is able to
extract the correct catalytic residues in PPT2 (Gln112, His283,
Asp228 and Ser111) using the active site motif (Gln116, His289,
Asp233 and Ser115) from PPT1 (Table 4). However, there are no
‘duplicate’ residues in the vicinity for PPT2 (Fig. 1c). It can be seen
that the best match with the active site scaffold has a distance of
7.5 A˚ between Gln142 and His283, in place of a distance of
13.3 A˚ in the cognate pair of Gln112 and His283 (Table 4). Such a
constricted site, with respect to PPT1, may also explain the lack of
activity of PPT2 against substrates that have bulky head groups
[34].
3. Lowest BrassIndex: Platelet-activating Factor
Acetylhydrolase (PDBid:1BWP)
Platelet-activating factor (PAF) is a very potent messenger
phospholipid, found in picomolar concentrations in fluids like
cytosol, blood plasma and urine [35]. PAF is implicated in several
critical physiological pathways, like activation of platelets and
monocytes [36] and modulation of cell proliferation [37]. The
Table 1. Proteins with highest and lowest BrassIndex :
L = sequence length.
PDB L Description
1QAM 244 ERMC’ METHYLTRANSFERASE
1OH9 258 ACETYLGLUTAMATE KINASE
1EH5 279 PALMITOYL THIOESTERASE 1
1QGX 357 3’-5’-ADENOSINE BISPHOSPHATASE
Highest 1DUB 261 2-ENOYL-COA HYDRATASE
2JXR 329 PROTEINASE A
2HGS 474 GLUTATHIONE SYNTHETASE
1D8H 311 mRNA TRIPHOSPHATASE CET1
1D2H 292 GLYCINE N-METHYLTRANSFERASE
1HZD 272 AU-BINDING PROTEIN/ENOYL-COA HYDRATASE
1BWP 233 PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE
1AKO 268 EXONUCLEASE III
1L1L 739 RIBONUCLEOSIDE TRIPHOSPHATE REDUCTASE
2DLN 306 D-ALANINE–D-ALANINE LIGASE
1NWW 149 LIMONENE-12-EPOXIDE HYDROLASE
Lowest 1EI5 520 D-AMINOPEPTIDASE
1NBA 264 N-CARBAMOYLSARCOSINE AMIDOHYDROLASE
1EC9 446 GLUCARATE DEHYDRATASE
3R1R 761 RIBONUCLEOTIDE REDUCTASE R1
1STD 172 SCYTALONE DEHYDRATASE
doi:10.1371/journal.pone.0049313.t001
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levels of PAF are tightly regulated by PAF acetylhydrolases (PAF-
AH), which inactivate PAF by hydrolyzing the ester bond [38].
Fig. 1d shows the active site residues of the alpha-1 subunit of the
isoform Ib of bovine brain intracellular PAF-AH, which indicates
very few ‘duplicate’ residues [39]. This fact is corroborated by data
shown in Table 5, which shows only one additional scaffold that
has both spatial and electrostatic congruence with the specified
catalytic motif. Y.S. Ho et al. have emphasized this very high
specificity (`
`
highly specific for PAF and effectively do not hydrolyze
phospholipids with acyl chains longer than acetate in the sn-2
position"), noting that this feature is ‘‘a hallmark of a regulatory
hydrolase’’ [39]. The ability of the BRASS methodology to
specifically select out such a protein as being highly selective adds
confidence to its underlying principle.
4. Relaxing Spatial Constraints and Allowing
Stereochemical Equivalence
CLASP provides the flexibility in the search process by allowing
a user to provide a defined set of residues to match a particular
position of the active site motif. Furthermore, the search algorithm
is parameterized to exclude matches if any pairwise distance
deviation exceeds a user specified threshold. In the default mode,
CLASP scores any pairwise deviation more than 2 A˚ in distance
highly, thus eliminating that match as a significant one. We
relaxed the spatial constraint, increasing this threshold distance to
5 A˚. We created the following groups - BASIC = [Lys His Arg],
ACIDIC = [Glu Asp], AMIDE = [Asn Gln], NONPOLAR = [Gly
Ala Val Leu Ile Met], AROMATIC = [Phe Trp Tyr], and applied
Figure 1. Active sites of proteins with the highest and lowest BrassIndex. (a) rRNA Methyltransferase (PDBid:1QAM): This protein has the
highest BrassIndex, as can be seen by the presence of various similar residues in close proximity, that results in electrostatically similar scaffolds as
well (Table 2). (b) Palmitoyl protein thioesterase 1 (PPT1) (PDBid:1EH5): Protein with the next highest BrassIndex. We hypothesize that a ‘replica’
catalytic triad consisting of Asp288 exists and is congruent to the known catalytic triad (His289, Asp233, Ser115) (Table 3). (c) Palmitoyl protein
thioesterase 2 (PPT2) (PDBid:1PJA): PPT2 has a 26% similarity with PPT1, but has a non-redundant role in the cell. The absence of supporting residues
could be a possible reason why PPT2 is unable to act upon all compounds (particularly those with have bulky head groups) which PPT1 catalyzes. (d)
Platelet-activating acetylhydrolase (PDBid:1BWP): This protein has the lowest BrassIndex, which is due to the absence of ‘duplicate’ residues in the
proximity of the core active site residues (Table 5). This implies that this protein has high specificity, a fact that has been noted in [39].
doi:10.1371/journal.pone.0049313.g001
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the BRASS algorithm to the chosen set of proteins under
consideration.
The more flexible search by BRASS identified a ketosteroid
isomerase (KSI) (PDBid:1C7H), which catalyzes an allylic
isomerization reaction at a diffusion-controlled rate, with a high
BrassIndex. The KSI uses a network of hydrogen bonds to connect
the critical residues Tyr16 and Asp103. Apart from these two
critical residues, Asp40 and Val104 constituted the active site
motif as specified in the CSA database (Asp103, Tyr16, Asp40 and
Val104). The non-critical residues were allowed to be substituted
by stereochemically equivalent residues, i.e. Asp104 and Val104
could be replaced by the elements of the groups BASIC and
NONPOLAR respectively. Table 6 shows that the vicinity of
Val104 has the following non-polar residues that may take up an
equivalent role - [Ile102, Ala118, Val101, Met105, Met116,
Met84, Val104, Val88, Val38, Ala118, Ile17, Ala83], a finding
that aligns well with the highly non-polar nature of the active site.
Furthermore, although the distance deviations are high, Glu39 can
be seen to be a possible substitute for Asp40.
5. Alkaline Phosphatase
Zinc binding sites are classified as catalytic, structural or
cocatalytic [40]. In cocatalytic sites, a single amino acid residue
(usually Asp or Glu) ligands two zinc ions in addition to other
ligands as the zinc ions are often penta-coordinate and arranged in
a trigonal bipyramidal geometry. In a cold-active Vibrio alkaline
phosphatase (VAP) (PDBid: 3E2D), there are three metal ions
similar to most other alkaline phosphatases - the M1 site (Asp273,
His277, His465) binds a zinc ion, the M2 site (Ser65, Asp315,
His316, Asp12) binds another zinc ion, while the M3 site (Asp12,
His116, Thr118, Glu268) binds a magnesium ion [41]. Asp12,
which is observed to ligand both the M2 and M3 ions, can be seen
to be redundant with Asp315 filling in for it (Table 7). It must be
admitted that the congruence is not such that it inspires absolute
confidence, and mutational studies would be required to confirm
this hypothesis. APs are broad specificity enzymes due to the fact
that the phosphorylgroup is the main chemical group of the
substrate that enters the active site and makes bonds with the
enzyme. Thus, the positional variants for the substrate are limited.
6. Frequency Distribution and Comparison to the
Promiscuity Index
Fig. 2a shows the frequency distribution of the BrassIndex on
the set of 420 proteins. It is seen that most proteins have a low
BrassIndex (high specificity). The number of proteins with broad
specificity (high BrassIndex) drops almost exponentially. We have
previously established a methodology to quantify promiscuous
activities in a wide range of proteins [20]. There was no detectable
correlation between the promiscuity index (computed as described
in [20]) and the BrassIndex (Fig. 2b). Furthermore, BrassIndex was
found to be independent of the threshold CLASP score used to
prune out unfeasible scaffolds.
Discussion
Evolution has shaped enzymes in accordance to their niche in
the cell. Varied physiological constraints have molded enzymes to
be mostly efficient [42], at times highly promiscuous [43], often
Table 2. Potential and spatial congruence of ‘duplicate’
scaffolds to the active site in a methyltransferase
(PDBid:1QAM).
Active site atoms (a,b,c) ab ac bc
GLY38N,ASN101OD1,GLU59OE1, D 9.5 4.7 10.9
PD 157.8 153.8 24
GLY40N,ASN101OD1,GLU59OE1, D 8.8 3.7 10.9
PD 222.6 218.6 24
GLY38N,ASN101OD1,GLU36OE1, D 9.5 5.9 10.3
PD 157.8 234.8 77.1
GLY40N,ASN101OD1,GLU36OE1, D 8.8 5.9 10.3
PD 222.6 299.6 77.1
GLY42N,ASN101OD1,GLU36OE1, D 11 6.2 10.3
PD 218.4 295.5 77.1
GLY40N,ASN11OD1,GLU59OE1, D 11.8 3.7 12.9
PD 184.4 218.6 34.2
The active site residues specified are Gly38, Asn101 and Glu59. D = Pairwise
distance in A˚. PD = Pairwise potential difference. See Methods section for units
of potential.
doi:10.1371/journal.pone.0049313.t002
Table 3. Potential and spatial congruence of ‘duplicate’ scaffolds to the active site in palmitoyl-protein thioesterase 1
(PDBid:1EH5).
Active site atoms (a,b,c,d) ab ac ad bc bd cd
GLN116NE2,HIS289NE2,ASP233OD1,SER115OG, D 9.7 14.2 6.3 5.3 3.6 8.3
PD 73.4 111.6 260.5 38.3 2133.9 2172.1
GLN182NE2,HIS289NE2,ASP233OD1,SER115OG, D 10.9 14.2 8.1 5.3 3.6 8.3
PD 64.2 102.5 269.6 38.3 2133.9 2172.1
GLN116NE2,HIS289NE2,ASP288OD1,SER115OG, D 9.7 16.5 6.3 7.4 3.6 10.8
PD 73.4 27.3 260.5 246 2133.9 287.8
GLN119NE2,HIS289NE2,ASP288OD1,SER115OG, D 9.1 15.6 6.2 7.4 3.6 10.8
PD 177.1 131 43.2 246 2133.9 287.8
GLN182NE2,HIS289NE2,ASP288OD1,SER115OG, D 10.9 16.5 8.1 7.4 3.6 10.8
PD 64.2 18.2 269.6 246 2133.9 287.8
The active site residues specified are Gln116, His289, Asp233, Ser115. D = Pairwise distance in A˚. PD = Pairwise potential difference. See Methods section for units of
potential.
doi:10.1371/journal.pone.0049313.t003
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precisely selective [39] and generally to possess broad, but related
substrate profiles [11]. Often, it is untenable to provide an in vitro
measure of these characteristics due to the laborious work
involved, and the huge number of enzymes being discovered
[14]. The rapid advancement in technology has allowed in silico
methodologies to address this requirement with predictive models
for some of these characteristics [20].
In the current work, we quantitatively characterize the active
site of an enzyme to measure broad substrate specificity - Broad
substrate specificity estimator (BRASS). We hypothesize that
‘duplicate’ residues generate slightly modified, both spatially and
electrostatically, replicas of the active site scaffold that are
responsible for a broad substrate profile. Finite difference Poisson
Boltzmann analysis is used as a discriminator to rule out
electrostatically unfavorable configurations [21,22]. BRASS com-
putes an index (BrassIndex) using the number of configurations
that are equivalent to the active site scaffold. Furthermore,
permutations of the original active site residues are also excluded,
due to the inability of our method to distinguish between mirror
images.
BRASS was applied to a set of non-homologous proteins
extracted from the Catalytic Site Atlas [24]. The frequency
distribution curve suggested that most proteins have high
specificity (Fig. 2a). This probably explains why promiscuity and
broad specificity are relatively new concepts [15], usurping the
older hypothesis that proteins are highly specific [44]. As expected,
there was no correlation found between the BrassIndex and the
promiscuity index (as computed in [20]) of a protein (Fig. 2b). The
residues, which are responsible for the promiscuous functionality,
in the vicinity of the catalytic residues may or may not bestow
additional specificity to the primary catalytic activity. This
uncertainty results in the lack of correlation in the promiscuity
and broad specificity indices. A platelet-activating factor acetylhy-
drolase (PAF-AH) (PDBid:1BWP) was identified as a protein with
the lowest BrassIndex in this set [39]. This PAF-AH, like most
regulatory enyzmes, is known to be highly specific for PAF [38].
Alongside this high specificity (i.e. low BrassIndex), the PAF-AH
has a low promiscuity index (0.11) [20]. These characteristics of
regulatory enzymes ensure that they are not preoccupied in
catalyzing irrelevant substrates or inhibited by them. The ability of
BRASS to select out such a protein gives credence to its underlying
theory. It is to be noted that this is an exceptional situation. As
dictated by the requirements of a regulatory enzyme, it should
have high specificity (low BrassIndex) and low promiscuity. A
random enzyme with high specificity need not satisfy this low
promiscuity criteria. Among the proteins with high BrassIndex was
an rRNA methyltransferase (MTase) [28] and a palmitoyl-protein
thioesterase (PPT1) [33]. Both these proteins are known to have
Table 4. Potential and spatial congruence of ‘duplicate’ scaffolds to the active site in palmitoyl-protein thioesterase 2
(PDBid:1PJA).
Active site atoms (a,b,c,d) ab ac ad bc bd cd
GLN112NE2,HIS283NE2,ASP228OD1,SER111OG, D 9.9 13.3 7.3 4.6 2.8 6.9
PD 272.3 22.9 2146.3 95.2 274.1 2169.3
GLN142NE2,HIS283NE2,ASP228OD1,SER111OG, D 8.4 7.5 8.5 4.6 2.8 6.9
PD 250.3 44.9 2124.4 95.2 274.1 2169.3
GLN142NE2,HIS283NE2,ASP47OD1,SER111OG, D 8.4 16.7 8.5 10.3 2.8 9.8
PD 250.3 39.2 2124.4 89.5 274.1 2163.6
GLN112NE2,HIS43NE2,ASP47OD1,SER79OG, D 10 12.3 6.2 7.4 6.6 8.4
PD 43.3 17.3 2131.9 226 2175.2 2149.2
The active site residues specified are Gln112, His283, Asp228, Ser111. D = Pairwise distance in A˚. PD = Pairwise potential difference. See Methods section for units of
potential.
doi:10.1371/journal.pone.0049313.t004
Table 5. Potential and spatial congruence of ‘duplicate’ scaffolds to the active site in a acetylhydrolase (PDBid:1BWP).
Active site atoms (a,b,c,d) ab ac ad bc bd cd
ASP192OD1,SER47OG,HIS195NE2,GLY74N, D 8.1 5.4 11.9 3.2 5.2 6.5
PD 2128.5 29.5 2177.2 157.9 248.7 2206.6
ASP192OD1,SER47OG,HIS195NE2,GLY73N, D 8.1 5.4 13.1 3.2 5.8 7.8
PD 2128.5 29.5 2188.4 157.9 260 2217.9
ASP75OD1,SER76OG,HIS79NE2,GLY102N, D 7.1 5.9 9.8 5.1 6.8 10.9
PD 2146.9 2144.3 2239.8 2.5 293 295.5
ASP46OD1,SER47OG,HIS195NE2,GLY74N, D 4.3 7.1 6.3 3.2 5.2 6.5
PD 2139.2 18.7 2187.9 157.9 248.7 2206.6
ASP182OD1,SER186OG,HIS180NE2,GLY177N, D 9.3 6.1 12.5 4.7 11.5 8.7
PD 2121.9 4.4 2218.6 126.4 296.6 2223
The active site residues specified are Asp192, Ser47, His195, Gly74.
D = Pairwise distance in A˚. PD = Pairwise potential difference. See Methods section for units of potential.
doi:10.1371/journal.pone.0049313.t005
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broad substrate specificities. Furthermore, the substrate specificity
of PPT1 is known to be broader than a homolog (PPT2), with
which it shares 26% identity [34]. BRASS analysis corroborated
this fact, since it failed to detect duplicate residues in PPT2 similar
to the ones found in PPT1.
Thus, BrassIndex applies to a particular enzyme, and is not a
characteristic of the class of enzymatic reactions. Directed
evolution is a generic term for methods that mimic and accelerate
evolution [45–48], often targeting the residues in the vicinity of the
catalytic site to yield faster result [49–51]. These directed evolution
methodologies can be applied to modulate specificities of a given
enzyme based on the BRASS specified duplicate residues. The
target residues can be identified by relaxing the spatial and/or
electrostatic constraints. In the current flow, such electrostatic
potential difference constraints prune out configurations that have
the required spatial attributes, but are not electrostatically
favorable [19]. However, the current method is not intended for
rational design of new functions. Such methods bestow a non-
existing function in a target protein, either by selecting a pre-
existing scaffold [52–57], or by using de novo approaches [58–62].
The mechanisms underlying the broad specificities possessed by
some enzymes have been the subject of intense research.
Table 6. Potential and spatial congruence of ‘duplicate’ scaffolds to the active site in a ketosteroid isomerase (PDBid:1C7H).
Active site atoms(a,b,c,d) ab ac ad bc bd cd
ASP103OD1,TYR16OH,ASP40OD1,VAL104N, D 5.8 6.6 4.8 8.5 8.8 10
PD 299.5 220.7 2284.8 78.8 2185.3 2264.2
ASP103OD1,TYR16OH,ASP40OD1,ILE102N, D 5.8 6.6 4.6 8.5 10.1 8.4
PD 299.5 220.7 2192.6 78.8 293.1 2171.9
ASP103OD1,TYR16OH,ASP40OD1,ALA118N, D 5.8 6.6 4.6 8.5 8.5 5.5
PD 299.5 220.7 2214 78.8 2114.5 2193.3
ASP103OD1,TYR16OH,ASP40OD1,VAL101N, D 5.8 6.6 6.6 8.5 10.9 8.9
PD 299.5 220.7 2247.6 78.8 2148.1 2226.9
ASP103OD1,TYR16OH,ASP40OD1,MET105N, D 5.8 6.6 7.3 8.5 9.3 12.3
PD 299.5 220.7 2313.8 78.8 2214.3 2293.1
ASP103OD1,TYR16OH,ASP40OD1,MET116N, D 5.8 6.6 8.5 8.5 8.5 10.5
PD 299.5 220.7 2323.2 78.8 2223.8 2302.6
ASP103OD1,TYR16OH,ASP40OD1,MET84N, D 5.8 6.6 7 8.5 10.7 13.3
PD 299.5 220.7 2263.8 78.8 2164.3 2243.2
ASP103OD1,TYR16OH,GLU39OE1,VAL104N, D 5.8 11.4 4.8 13 8.8 9.9
PD 299.5 2103.9 2284.8 24.4 2185.3 2180.9
ASP103OD1,TYR16OH,ASP40OD1,VAL88N, D 5.8 6.6 9.6 8.5 11.1 11.1
PD 299.5 220.7 2266.8 78.8 2167.3 2246.2
ASP103OD1,TYR16OH,ASP40OD1,VAL38N, D 5.8 6.6 10.8 8.5 9.8 9.6
PD 299.5 220.7 2237.5 78.8 2138 2216.9
ASP103OD1,TYR16OH,GLU39OE1,ALA118N, D 5.8 11.4 4.6 13 8.5 7.3
PD 299.5 2103.9 2214 24.4 2114.5 2110.1
ASP103OD1,TYR16OH,ASP40OD1,ILE17N, D 5.8 6.6 9.5 8.5 6.8 14.3
PD 299.5 220.7 2325.9 78.8 2226.4 2305.2
ASP103OD1,TYR16OH,ASP40OD1,ALA83N, D 5.8 6.6 9.2 8.5 12.2 15.3
PD 299.5 220.7 2325.4 78.8 2225.9 2304.7
The active site residues specified are Asp103, Tyr16, Asp40, Val104. D = Pairwise distance in A˚. PD = Pairwise potential difference. See Methods section for units of
potential.
doi:10.1371/journal.pone.0049313.t006
Table 7. Residues liganding magnesium ion in VAP.
Active site atoms (a,b,c,d) ab ac ad bc bd cd
ASP12OD1,HIS116NE2,THR118OG1,GLU268OE1, D 8.2 5.1 7 7.2 7.3 3.8
PD 2460.7 2206.5 2291.6 254.2 169 285.2
ASP315OD1,HIS116NE2,THR118OG1,GLU268OE1, D 10.9 5.8 8.3 7.2 7.3 3.8
PD 2282.3 228.1 2113.3 254.2 169 285.2
Asp315 can be seen to able to partially substitute for Asp12. D = Pairwise distance in A˚. PD = Pairwise potential difference. See Methods section for units of potential.
doi:10.1371/journal.pone.0049313.t007
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Molecular dynamics simulations have been used to study the basis
of the broad substrate profile of cytochrome P450 (CYP) 3A4,
which catalyzes the oxidative degradation of a wide range of
compounds [63]. The study concluded that `the broad substrate
specificity of CYP3A4 stems from the malleability of a loop
(residues 211–218) that resides in the vicinity of the channel
connecting the active site and bulk solvent’. Table S1 shows that
keeping the core catalytic residues (Thr309, Glu308, Phe435 and
Cys442) constant, there are four possibilities for the torsional
position of Phe215, a residue that has the maximum` change in
dynamic flexibilities of the different regions of protein structure
due to ligand binding’. Two of the four candidates lie in the loop
211–218. Another computational study evaluated the electrostatic
and van der Waals interactions between substrates and active site
residues in order to ‘provide a basis to understand the catalytic role
of conserved residues, the substrate specificity, and the relative
activity of favorable substrates’ [64]. Once again they concluded
that`structural features of the substrate-binding site and the van
der Waals and electrostatic interactions between substrates and the
conserved residues lead to the broad substrate recognition’. It has
been our attempt to quantify these parameters (using a static
model) by exploiting the electrostatic and spatial congruence of
neighboring residues.
The physiological needs that modulate the specificities of
enzymes might be understood by a study of the evolutionary
related penicillin binding proteins (PBP) and serine b-lactamases,
where a nucleophilic serine in the conserved SXXK motif forms
an acyl-complex with b-lactam antibiotics [65]. Ideally, PBP’s
should have evolved to be very specific for the D-alanyl-D-alanine
end of the peptidoglycan, which they cross-link as the last step of
peptidoglycan synthesis. The b-lactam antibiotics mimic the D-
alanyl-D-alanine portion and act as ‘suicide substrates’, thus
inhibiting cell wall synthesis. The broad specificity in PBP’s is
exploited by designing b-lactam drugs (penicillins, carbapenems
and cephalosporins) that conserve the b-lactam ring, but differ in
other regions of their chemical structure. It has been hypothesized
that b-lactamases have evolved from the PBP’s to gain the ability
to cleave the b-lactam ring, rendering the drugs ineffective [66].
The same phenomenon of broad specificity allows a single b-
lactamase enzyme to hydrolyze a diverse range of drugs [7].
Conversely by reducing the range of the specificity of PBP’s, the
methicillin-resistant strains of Staphylococcus aureus have evolved a
PBP (PBP2a) with low affinity for b-lactams [67].
BRASS essentially works on a static model. However, it
implicitly includes dynamics based on the ‘flexibility’ of the
main-chain scaffold and mobility of selected side chains inside
prearranged folds or ensembles of conformation. The reason for
‘good’ binding or improved selectivity may be distal to the prime
residues in the active site. These residues are considered by
allowing for spatial variability, of course under the assumption that
the distant residues primarily reinforce what their closer counter-
parts do by allowing for spatial variability. In alkaline phospha-
tases, residues in the secondary valence shell around the metal ions
have effect on catalysis, e.q. by selecting magnesium in the M3-site
and keeping correct coordination for catalysis (octahedral,
tetrahedral, etc.) [68].
A caveat in the computation of an index like the BrassIndex is
the reliability of the manual step in specifying the set of residues
involved in the catalytic reaction. It is not possible to computa-
tionally figure out whether two closely placed residues are both
essential or redundant for catalysis. In spite of this inevitable
source of error, the number of residues that have proximal
‘duplicate’ candidates is a good benchmark for estimating
BrassIndex. Electrostatic analysis of the congruence of the
specified active site motif with the other ‘replicas’ is another
metric used as a discriminator. It should be mentioned that
BRASS is unable to detect if and how an enzyme has a specific
stereospecificity or steroselectivity, and is simply guided by the
specified active site residues. In summary, we quantitatively
characterize the properties of an enzyme which results in broad
substrate specificity, using spatial and electrostatic properties of
residues in the active site and its close vicinity.
Methods
1 Materials
Adaptive Poisson-Boltzmann Solver (APBS) and PDB2PQR
packages were used to calculate the potential difference between
the reactive atoms of the corresponding proteins [22,69]. The
APBS parameters were set as described previously in [19]. APBS
writes out the electrostatic potential in dimensionless units of kT/e
where k is Boltzmann’s constant, T is the temperature in K and e
Figure 2. Statistics of BrassIndex on the population: (a) Frequency distribution of BrassIndex. It can be seen that most proteins are
highly specific (low BrassIndex), and the number of proteins with high specificity drops exponentially. (b) Lack of correlation between
promiscuity and substrate specificity (Brass) indices: As expected, there is no correlation between promiscuity (defined as the ability to
catalyze reactions distinct from the one the protein has evolved to perform, but using the same active site scaffold) and the ability of enzymes to
catalyze the reaction of different, but related, compounds using the same catalytic mechanism (broad substrate specificity). The promiscuity indices
are computed as described in [20].
doi:10.1371/journal.pone.0049313.g002
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is the charge of an electron. We extensively integrated and used
the freely available BioPerl [70] modules and Emboss [71] tools.
All protein structures were rendered by PyMol (http://www.
pymol.org/).
2 Methodology
The underlying theoretical foundation for CLASP is the non-
triviality of the spatial and electrostatic congruence in cognate
pairs seen across various structures with the same catalytic
mechanism. Table S2 shows the congruence in serine proteases.
The two major families of serine proteases, chymotrypsin and
subtilisin, are a classical example of convergent evolution where
the catalytic Ser-His-Asp triad shows virtually similar geometry
in the structurally different chymotrypsin and subtilisin [72].
This invariance in the electrostatic features (measured in
structures that have been solved independently over many
years) is an innate property required for the enzymatic activity.
This also speaks highly of the reliability of the APBS/
PDB2PQR implementation.
BRASS starts with a motif consisting of N residues from the
catalytic site of a protein (Pi) (Equation 1). All sets of N residues
(Equation 2 and 3) are obtained in the same protein using an
exhaustive search procedure similar to the one used in SPASM
[73]. The pairwise distances and potential differences are
computed for each match, and compared with the original
motif. This generates the CLASP score, which defines an
ordering of the matches (Equation 3). The CLASP score
consolidates the distance and the potential difference scores,
and reflects the likelihood that the activity in the reference
protein exists in the query protein.
M1 represents the specified active site scaffold of the protein,
and has a CLASP score of zero. All matches below a user
defined threshold score (Sthresh) are discarded. The index for
the degree of specificity should encapsulate the number of
scaffolds that are similar to the original active site, as well as
the quality of the matches which are reflected by the CLASP
scores (Equation 4). Furthermore, we ignore scaffolds which do
not include at least one of the known active site residues. Such
a moonlighting activity, even if true, is not of interest in the
current work.
The BRASS methodology can be extended to incorporate
stereochemically equivalent residues in the match. Each
position of the motif can have a set of amino acids specified
to allow for stereochemically equivalent matches at that
particular position (Equation 5). This introduces an additional
constraint while matching each residue, ensuring that the
amino acid type of ri (Equation 2) belongs to GROUPi
(Equation 5).
Qresidues
i~fR1,R2,::RNg ð1Þ
Mi~fr1,,r2,:::rng ð2Þ
Qmatches
sorted~fM1,M2:::Mkg,
½ScoreM1vScoreM2,ScoreM2vScoreM3:::
ScoreMkvScorethresh
ð3Þ
BrassIndexPi~
X
0MivK (1{ScoreMi) ð4Þ
Qgroups~fGROUP1,GROUP2:::GROUPNg ð5Þ
To summarize, the active site signature for each protein is used
to query itself, generating a list of scaffolds with an associated
CLASP score. Lower CLASP scores denote better congruence,
and we discard all matches whose scores are more than a user
defined threshold. The BrassIndex for the enzymatic function
of a protein is now defined by the number of scaffolds that can
serve as ‘replicas’ of the original scaffold. The BrassIndex is
normalized such that the protein with the broadest specificity
has BrassIndex of 1.
An inherent limitation of CLASP, and typical of other methods
that use RMSD, is its inability to distinguish between mirror
images. Thus, permutations of the original active site are also
excluded. We compute the BrassIndex for a non-homologous set
of proteins with known active site and structure extracted from the
CSA database [24]. The source code has been made available at
www.sanchak.com/brass.html.
3. Dataset Selection
CSA provides catalytic residue annotation for enzymes in
the PDB and is available online [24]. The database consists of
an original hand-annotated set extracted from the primary
literature and a homologous set inferred by PSI-BLAST [74].
The motifs picked were those that were extracted from the
literature, had either 3, 4 or 5 residues and were all confined to
one polypeptide. The extended set of proteins now has 420
proteins. Some proteins were excluded since they failed the
electrostatic analysis. Table S3 shows the proteins in our test
set.
Supporting Information
Table S1 BRASS results for Cytochrome P450 3A4
(PDBid:3UA1): A flexible loop (residues 211–218) is
proposed to be the reason for the broad substrate
specificity [63]. BRASS identifies four possibilities for the
torsional position of Phe215, which is shown to have the
maximum shift upon substrate binding. The core catalytic residues
are - Thr309, Glu308, Phe435 and Cys442.
(PDF)
Table S2 Potential and spatial congruence of the
active site residues in serine proteases: Chymotryp-
sin and subtilisin are a classical example of conver-
gent evolution where the catalytic Ser-His-Asp triad
shows virtually similar geometry in the structurally
different proteins. D = Pairwise distance in A˚. PD = Pair-
wise potential difference. See Methods section for units of
potential.
(PDF)
Table S3 Set of non-homologous proteins with known
active site residues: The proteins are ordered in an
ascending order with respect to the BrassIndex.
(PDF)
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